⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
ATUL - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.4
| Stock Code | ATUL | Market Cap | 18,478 Cr. | Current Price | 6,276 ₹ | High / Low | 7,793 ₹ |
| Stock P/E | 35.8 | Book Value | 1,973 ₹ | Dividend Yield | 0.40 % | ROCE | 11.9 % |
| ROE | 8.64 % | Face Value | 10.0 ₹ | DMA 50 | 6,013 ₹ | DMA 200 | 6,261 ₹ |
| Chg in FII Hold | -0.86 % | Chg in DII Hold | 0.46 % | PAT Qtr | 121 Cr. | PAT Prev Qtr | 172 Cr. |
| RSI | 59.1 | MACD | 26.6 | Volume | 1,11,544 | Avg Vol 1Wk | 36,268 |
| Low price | 4,752 ₹ | High price | 7,793 ₹ | PEG Ratio | -4.41 | Debt to equity | 0.00 |
| 52w Index | 50.1 % | Qtr Profit Var | 30.8 % | EPS | 176 ₹ | Industry PE | 25.9 |
📊 Core Financials
- Revenue & Profitability: Quarterly PAT fell to 121 Cr. from 172 Cr., showing earnings pressure. EPS stands at 176 ₹.
- Margins: ROCE at 11.9% and ROE at 8.64% indicate moderate efficiency and profitability.
- Debt: Debt-to-equity ratio of 0.00 reflects a debt-free balance sheet.
- Cash Flow: Stable operations but declining profits may impact cash generation.
💹 Valuation Indicators
- P/E Ratio: 35.8, higher than industry average of 25.9, suggesting mild overvaluation.
- P/B Ratio: Current price (6276 ₹) vs. book value (1973 ₹) shows a premium valuation.
- PEG Ratio: -4.41, indicating weak growth prospects relative to valuation.
- Intrinsic Value: Current market price appears slightly stretched compared to fundamentals.
🏢 Business Model & Competitive Advantage
- Diversified presence in chemicals, polymers, and specialty products.
- Strong brand reputation and established client base.
- Debt-free structure enhances financial resilience.
📈 Entry Zone & Long-Term Guidance
- Entry Zone: Attractive accumulation range lies between 5,200–5,600 ₹, given current valuation premium.
- Long-Term Holding: Suitable for investors seeking exposure to specialty chemicals, but growth moderation requires cautious entry.
✅ Positive
- Debt-free balance sheet ensures financial stability.
- Strong EPS of 176 ₹ supports long-term value creation.
- Established brand in specialty chemicals with diversified portfolio.
⚠️ Limitation
- Quarterly PAT declined from 172 Cr. to 121 Cr., showing earnings pressure.
- ROCE (11.9%) and ROE (8.64%) are moderate compared to peers.
- PEG ratio negative (-4.41), indicating weak growth outlook